
P065: Cell Mimics as Reliable Controls for Consistent, Reproducible Flow Cytometry Assays in Cell Therapy | View Poster
P071: Development and Characterization of Synthetic Extracellular Vesicle (EV) Mimics for Enhanced Flow Cytometry Standardization | View Poster
P004: Advancing Flow Cytometry for T-cell Activation and Exhaustion Analysis with Single Biomarker Cell Mimic Controls | View Poster
P078: Use of custom TruCytes™ cell mimics as an internal assay control to validate a prognostic flow cytometry test quantifying FcγRIIa expression on fixed platelets | View Poster
cyto2025, cyto 2025, cyto 2026
Slingshot Biosciences is at the forefront of bioscience innovation, specializing in advanced products that enhance flow cytometry and cell therapy applications. The company focuses on developing cell mimics that serve as reliable controls in laboratory settings, ensuring consistency and reproducibility in experimental results.
With a commitment to scientific advancement, Slingshot Biosciences provides a range of products designed to meet the evolving needs of researchers and clinicians. Their expertise in creating synthetic biomaterials positions them as leaders in the field, contributing to breakthroughs in diagnostics and therapeutic development.
Cell mimics play a crucial role in flow cytometry, acting as standards that help validate assays and ensure accurate measurements. By using these synthetic controls, researchers can achieve more reliable data, which is essential for the advancement of cell therapy and diagnostics.
For instance, the use of TruCytes™ cell mimics allows for the standardization of flow cytometry tests, enabling researchers to quantify specific biomarkers with confidence. This innovation not only enhances the quality of research but also supports the development of new therapeutic approaches in clinical settings.
The CYTO 2025 conference showcased a variety of innovative research topics related to flow cytometry and cell therapy. Presentations included advancements in the development of synthetic extracellular vesicle mimics and their implications for standardization in flow cytometry.
Among the notable presentations was a study on the use of custom TruCytes™ cell mimics as internal assay controls. This research highlights the importance of reliable controls in validating prognostic tests, particularly in quantifying FcγRIIa expression on fixed platelets, which is critical in clinical diagnostics.
Users interested in the latest advancements in flow cytometry can access downloadable posters presented at the CYTO 2025 conference. These posters provide insights into cutting-edge research and methodologies, making them valuable resources for scientists and clinicians alike.
To view and download the posters, simply click on the links provided on our website. Each poster offers a detailed overview of the research presented, including methodologies, results, and implications for future studies in the field of cell therapy and diagnostics.